EU Industrial Sovereignty at Risk Five Sectors Critically Dependent on China
Gold Mining Sectors Q1 Earnings Suggest Bullish Momentum May Persist
Silver Price Outlook Could the Metal Surpass 100 in the Next Decade
Inflation Strains Holiday Weekend Budgets as Travel Recreation and Food Prices Rise Most
Applied Materials Reports Quarterly Revenue Above Market Expectations
Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Key Market Moves to Watch
IMPPP Q1 2026 Earnings Preferred EPS Surges Past Estimates on Strong Operating Performance
INFQ Q1 2026 Earnings Loss Per Share Widens Stock Surges on No Estimate Comparison
MMYT Q1 2026 Earnings EPS Miss Sends Stock Lower Despite Strong Travel Demand
Gladstone Land Corporation LANDP Q1 2026 Earnings Preferred Shares Beat Estimates Despite Negative EPS
IART Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain
MS Q1 2026 Earnings Earnings Beat by 1092 as EPS Surges to 343
Cohen Steers LDP Holds Steady Near Support Amid Preferred Income Stability
Primoris Services Corporation PRIM Slips 3 as Infrastructure Stock Faces Resistance
SiriusPoint Ltd SPNT Declines 2 as Sector Headwinds Test Key Support
Gabelli MultiMedia Trust GGT Holds Steady Near Support as Consolidation Continues
REE Automotive Bounces from Support Tests Resistance at 046
Booking Holdings Launches Unified BKNG Ads Platform to Streamline Advertising Across Brands
YETI Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher
BWNB Senior Notes Hold Steady Near Par as Support and Resistance Levels Tighten
COYA Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Efficiency Gains
TALK Q1 2026 Earnings Significant EPS Miss Amid Operational Uncertainty
Xtant Medical Holdings Inc XTNT Q1 2026 Earnings EPS Misses Estimates Amidst Narrow Loss
AB Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds
PBF Energy Q1 2026 Earnings Refining Headwinds Drive WiderThanExpected Loss
MHO Q1 2026 Earnings EPS Slightly Beats Estimate Stock Holds Steady
SION Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment